Atlas Trials

Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy

Clinical trial NCT04741074 · TERMINATED

Trial details

NCT number
NCT04741074
Sponsor
Geisinger Clinic
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
CKDDiabetic Kidney DiseaseType 2 Diabetes Mellitus in ObeseObesitySevere Obesity
Start date
2021-07-23
Primary completion
2023-01-31
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.